
Merrimack Pharma Plans Voluntary NASDAQ Delisting Pending Stockholder Approval for Dissolution
Merrimack Pharmaceuticals (NASDAQ: MACK) has notified NASDAQ of its intention to delist its securities, pending stockholder approval of the Plan of Dissolution at the scheduled Special Meeting on May 10,…










